Search Result "Niraparib"
PARP Inhibitors in Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 4 Year: 2018 Page: 392-410
Author(s): Gloria Mittica,Eleonora Ghisoni,Gaia Giannone,Sofia Genta,Massimo Aglietta,Anna Sapino,Giorgio Valabrega
Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 16 Issue: 2 Year: 2018 Page: 108-117
Author(s): Wei-Hua Shao,Lei-Yun Wang,Ji-Ye Yin
A Review on Poly (ADP-ribose) Polymerase (PARP) Inhibitors and Synthetic Methodologies
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 8 Year: 2021 Page: 1565-1584
Author(s): Ying Li,Chen-Fu Liu,Guo-Wu Rao
RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARPInhibitors
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 11 Year: 2023 Page: 900-909
Author(s): CÃntia Regina Niederauer Ramos,Renato José Silva Oliveira,Marcela Nunes Rosa,Ariane Stéfani Pereira,Renata Barbosa Vahia de Abreu,Andre van Helvoort Lengert,Rui Manuel Reis,Viviane Aline Oliveira Silva,Edenir Inêz Palmero,Matias Eliseo Melendez
Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance
Journal: Current Drug Targets
Volume: 21 Issue: 2 Year: 2020 Page: 167-178
Author(s): Ling Wang,Qi Wang,Yangchun Xu,Manhua Cui,Liying Han
Advancements in Anticancer Drug Delivery
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 9 Year: 2018
Author(s): Hemant K.S. Yadav,Abrar E. Srouji,Alyazya Mohammed,Manar Dibi
Doi: 10.2174/9781681087016118090009
Hetero Cyclic Compounds in the Treatment of Triple-Negative BreastCancer
Journal: Current Cancer Therapy Reviews
Volume: 19 Issue: 3 Year: 2023 Page: 237-259
Author(s): Sudip Kumar Mandal,Biplab Kumar Dey,Santosh Kumar Rath
Synthesis and In Silico Studies of Quinazolinones as PARP-1 Inhibitors
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 27 Issue: 9 Year: 2024 Page: 1329-1343
Author(s): Ankit Kumar Singh
Efficacy and Safety of PARP Inhibitor Therapy in Advanced OvarianCancer: A Systematic Review and Network Meta-analysis of RandomizedControlled Trials
Journal: Current Computer-Aided Drug Design
Volume: 20 Issue: 6 Year: 2024 Page: 736-751
Author(s):
PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Journal: Current Drug Targets
Volume: 19 Issue: 1 Year: 2018 Page: 21-37
Author(s): Dalia Kamel,Christopher Gray,Jagdeep Singh Walia,Vikaash Kumar